Brent Kearney

Posted on: July 27th, 2006 @ 14:35

Nicotine Addiction There is a story coming through the Associated Press today about a new generation of anti-smoking drugs. This one is more like a vaccine than the nicotine-replacement therapies presently on the market. Pfizer Inc.’s “Chantix“, and Sanofi-Aventis SA’s “Acomplia” work as a vaccine, stimulating the smoker’s immune system to fight nicotine as if it were an infection. Additional treatments cause the production of antibodies that prevent nicotine from crossing the blood-brain barrier, ridding cigarettes of their most addictive effect. This is promising news for civilization!

Add comment